Opinion

Most Recent

image: Opinion: Is a Clone Really Born at Age Zero?

Opinion: Is a Clone Really Born at Age Zero?

By | February 21, 2017

More lessons from Dolly the sheep

1 Comment

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: Should Scientists Engage in Activism?

Opinion: Should Scientists Engage in Activism?

By | February 7, 2017

Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

12 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Opinion: Preparing for Potential Disasters

Opinion: Preparing for Potential Disasters

By | January 25, 2017

How to increase the resiliency of biotechnology organizations in the face of emergency risks

0 Comments

image: Opinion: Reuse and Reduce

Opinion: Reuse and Reduce

By | January 16, 2017

Sharing leftover samples from preclinical experiments is one way biomedical researchers can make the most of animal models.

1 Comment

image: Opinion: Aging, Not a Disease

Opinion: Aging, Not a Disease

By | December 23, 2016

A response to “Opinion: Aging, Just Another Disease” 

8 Comments

image: Opinion: A Tale of Two Hemispheres

Opinion: A Tale of Two Hemispheres

By | December 20, 2016

Studying savant-like behaviors in birds could help researchers better understand autism spectrum disorders.

0 Comments

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham